Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7U0C

Crystal structure of broadly neutralizing antibody HEPC3.4

Summary for 7U0C
Entry DOI10.2210/pdb7u0c/pdb
DescriptorHEPC3.4 Fab Heavy Chain, HEPC3.4 Fab Light Chain (2 entities in total)
Functional Keywordshcv glycoprotein, broadly neutralizing antibodies, antiviral protein, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains6
Total formula weight145965.69
Authors
Flyak, A.I.,Bjorkman, P.J. (deposition date: 2022-02-17, release date: 2022-06-08, Last modification date: 2024-11-13)
Primary citationBozhanova, N.G.,Flyak, A.I.,Brown, B.P.,Ruiz, S.E.,Salas, J.,Rho, S.,Bombardi, R.G.,Myers, L.,Soto, C.,Bailey, J.R.,Crowe Jr., J.E.,Bjorkman, P.J.,Meiler, J.
Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individuals.
Nat Commun, 13:3178-3178, 2022
Cited by
PubMed Abstract: Despite recent success in hepatitis C virus (HCV) treatment using antivirals, an HCV vaccine is still needed to prevent reinfections in treated patients, to avert the emergence of drug-resistant strains, and to provide protection for people with no access to the antiviral therapeutics. The early production of broadly neutralizing antibodies (bNAbs) associates with HCV clearance. Several potent bNAbs bind a conserved HCV glycoprotein E2 epitope using an unusual heavy chain complementarity determining region 3 (HCDR3) containing an intra-loop disulfide bond. Isolation of additional structurally-homologous bNAbs would facilitate the recognition of key determinants of such bNAbs and guide rational vaccine design. Here we report the identification of new antibodies containing an HCDR3 disulfide bond motif using computational screening with the Rosetta software. Using the newly-discovered and already-known members of this antibody family, we review the required HCDR3 amino acid composition and propose determinants for the bent versus straight HCDR3 loop conformation observed in these antibodies.
PubMed: 35676279
DOI: 10.1038/s41467-022-30865-9
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.3 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon